You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphocytic Leukemia, Lymphoma Trial in New York (Biological/Genetically Modified T cells, Cyclophosphamide-based chemo)

Active, not recruiting
  • Acute Lymphocytic Leukemia
  • Lymphoma
  • Biological/Genetically Modified T cells
  • Cyclophosphamide-based chemotherapy
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 3, 2023

Epstein-Barr Virus Infections, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)

Recruiting
  • Epstein-Barr Virus Infections
  • Primary Immune Deficiency Disorder
  • cytotoxic t-lymphocytes
  • Los Angeles, California
  • +7 more
Sep 27, 2022

CMV Infection, EBV Infection, Stem Cell Transplant Trial (Virus specific T cells)

Not yet recruiting
  • CMV Infection
  • +2 more
  • Virus specific T cells
  • (no location specified)
Oct 4, 2023

Epstein-Barr Virus Infections, Adenovirus, Cytomegalovirus Infections Trial in Milwaukee (Cytotoxic T Lymphocytes)

Completed
  • Epstein-Barr Virus Infections
  • +2 more
  • Cytotoxic T Lymphocytes
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Oct 21, 2021

Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,

Recruiting
  • Hodgkin Disease
  • +5 more
  • MABEL CTLs
  • +2 more
  • Houston, Texas
  • +1 more
Jan 13, 2023

Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type, Classical Hodgkin Lymphoma Trial in Houston (CD30.CAR-EBVST cells)

Recruiting
  • Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
  • Classical Hodgkin Lymphoma
  • CD30.CAR-EBVST cells
  • Houston, Texas
  • +1 more
Jul 20, 2022

Epstein-Barr Virus Infections, Cytomegalovirus Infections, Adenovirus Trial in New York (Rapidly generated virus specific T

Not yet recruiting
  • Epstein-Barr Virus Infections
  • +3 more
  • Rapidly generated virus specific T (R-MVST) cells
  • New York, New York
    Columbia University Irving Medical Center
Feb 18, 2022

EBV Lymphoma, Post-transplant Lymphoproliferative Disease (PTLD) Trial in Switzerland (Donor-derived ex-vivo expanded EBV Tscm

Not yet recruiting
  • EBV Lymphoma
  • Post-transplant Lymphoproliferative Disease (PTLD)
  • Donor-derived ex-vivo expanded EBV Tscm CTL
  • Basel, Switzerland
  • +7 more
Jan 25, 2023

AdV Infection, EBV Infection, CMV Infection Trial in Worldwide (Multivirus (CMV, EBV, AdV)-specific T cells)

Recruiting
  • AdV Infection
  • +3 more
  • Multivirus (CMV, EBV, AdV)-specific T cells
  • Brussels, Belgium
  • +25 more
Feb 14, 2022

EBV-induced Lymphomas, EBV-associated Malignancies, Transplant Patients With EBV Viremia at High Risk of Developing a Recurrent

Completed
  • EBV-induced Lymphomas
  • +2 more
  • allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes (EBV-CTLs)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 21, 2020

Epstein-Barr Virus (EBV) Infections, Lymphoproliferative Disorders, EBV+ Associated Lymphoma Trial (tabelecleucel)

Available
  • Epstein-Barr Virus (EBV) Infections
  • +11 more
  • tabelecleucel
  • (no location specified)
Feb 15, 2022

Adenovirus, Cytomegalovirus Infections, Epstein-Barr Virus Infections Trial in Pittsburgh (Specific T- Lymphocytes)

Not yet recruiting
  • Adenovirus
  • +2 more
  • Specific T- Lymphocytes
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Sep 8, 2023

Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (PID LPD), EBV+

Recruiting
  • Epstein-Barr Virus (EBV)-Associated Diseases
  • +13 more
  • Tabelecleucel
  • Los Angeles, California
  • +39 more
Nov 9, 2022

Adenovirus Infection, BK Virus Infection, Cytomegalovirus Infections Trial in Worldwide (Posoleucel (ALVR105), Placebo)

Recruiting
  • Adenovirus Infection
  • +5 more
  • Posoleucel (ALVR105)
  • Placebo
  • Birmingham, Alabama
  • +60 more
Mar 30, 2022

Epstein-Barr Virus Infections Trial in Houston (Intravenous injection of EBV specific CTLS)

Completed
  • Epstein-Barr Virus Infections
  • Intravenous injection of EBV specific CTLS
  • Houston, Texas
  • +1 more
Jan 15, 2020

Immunodeficiency for Severe Epstein-Barr Virus Infection

Recruiting
  • Epstein-Barr Virus Infections
  • Immunodeficiency
    • Shanghai, Shanghai, China
      Children's Hospital of Fudan University
    Mar 21, 2022

    Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications,

    Recruiting
    • Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
    • +4 more
    • tabelecleucel
    • Duarte, California
    • +70 more
    Jun 23, 2022

    Epstein-Barr Virus Infections, Lymphoproliferative Disorders Trial in Houston (Intravenous injection of EBV specific CTLs)

    Completed
    • Epstein-Barr Virus Infections
    • Lymphoproliferative Disorders
    • Intravenous injection of EBV specific CTLs
    • Houston, Texas
    • +1 more
    Jan 15, 2020

    CMV Viremia, CMV Trial in São Paulo (Lymphocyte infusion (ImmuneCellVir-I))

    Recruiting
    • CMV Viremia
    • CMV
    • Lymphocyte infusion (ImmuneCellVir-I)
    • São Paulo, SP, Brazil
      Hospital Israelita Albert Einstein
    Aug 21, 2023

    Viral Infection After HSCT Trial (Virus -specific T cells)

    Not yet recruiting
    • Viral Infection After HSCT
    • Virus -specific T cells
    • (no location specified)
    Mar 28, 2022

    Allogeneic Stem Cell Transplant, Viral Infection, Viral Reactivation Trial in Cincinnati (Viral specific VST Infusion)

    Recruiting
    • Allogeneic Stem Cell Transplant
    • +2 more
    • Viral specific VST Infusion
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Aug 15, 2022

    Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Lymphoproliferative Disorder Trial in Houston (LMP specific T cells)

    Completed
    • Hodgkin Lymphoma
    • +5 more
    • LMP specific T cells
    • Houston, Texas
    • +1 more
    Feb 5, 2020

    Nasopharyngeal Carcinoma Trial in Worldwide (autologous EBV specific Cytotoxic T cells, combination IV gemcitabine and IV

    Active, not recruiting
    • Nasopharyngeal Carcinoma
    • autologous EBV specific Cytotoxic T cells
    • combination IV gemcitabine and IV carboplatin (AUC2)
    • Duarte, California
    • +29 more
    Mar 5, 2021

    EBV Associated Extranodal NK/T-cell Lymphoma, EBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma Trial in Korea,

    Recruiting
    • EBV Associated Extranodal NK/T-cell Lymphoma
    • EBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma
    • EBViNT Cell
    • Seoul, Gangnam-gu, Korea, Republic of
    • +7 more
    Jul 7, 2022

    Immune Function and PD-1 Antibody Therapy Efficacy Predictors on

    Recruiting
    • Secondary Hemophagocytic Lymphohistiocytosis
    • Chronic Active Epstein-Barr Virus Infection
    • No intervention
    • Beijing, Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    May 2, 2023